Price $3.42 |
Market Cap
214M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.36
|
P/S
118.29
|
Dividend %
-
|
|
P/CF
22.6
|
P/FCF
-
|
Op. Cash Flow
-34.1K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-82.10%
|
ROI
-70.40%
|
|
ROA
-63.50%
|
EPS Growth
14.00%
|
Current Ratio
5.6
|
Debt/Equity
13.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acorda Therapeutics Inc (ACOR) | $14.30 | - | - | 790.9M | Strong Buy |
| BioScrip Inc (BIOS) | $3.61 | - | - | 464.8M | Strong Buy |
| TearLab Corp (TEAR) | $0.08 | - | - | 1M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.37 | - | - | 14.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.87 | - | - | 26M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
